<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-ONC-16010221</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2016-12-22</date_registration>
      <primary_sponsor>Department of Hematology, General Hospital of the Air Force</primary_sponsor>
      <public_title>Haplo-identical transplantation for acquired severe aplastic anaemia</public_title>
      <acronym />
      <scientific_title>Haplo-identical transplantation for acquired severe aplastic anaemia</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2017-01-01</date_enrolment>
      <type_enrolment />
      <target_size>haplo-HSCT:34;HSCT:34;</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=17142</url>
      <study_type>Observational study</study_type>
      <study_design>Cohort study</study_design>
      <phase>New Treatment Measure Clinical Study</phase>
      <hc_freetext>aplastic anemia</hc_freetext>
      <i_freetext>haplo-HSCT:haplo-HSCT;HSCT:HSCT;</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Han Dongmei</firstname>
        <middlename />
        <lastname />
        <address>30 Fucheng Road, Haidian, Beijing</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 13439752779</telephone>
        <email>handm1981@sina.com</email>
        <affiliation> General Hospital of the Air Force</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Wang Hengxiang</firstname>
        <middlename />
        <lastname />
        <address>30 Fucheng Road, Haidian, Beijing</address>
        <city />
        <country1 />
        <zip />
        <telephone>+86 15611161119</telephone>
        <email>wanghengxiang123@aliyun.com</email>
        <affiliation> General Hospital of the Air Force</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. SAA, including patients with type I and type II SAA;
2. between the ages of 1-50 years old, male or female;
3. families signed the informed consent and donor signed the hematopoietic stem cell donation consent;
4. non HLA matched donor;
5. severe transfusion dependent patients;
6. invalid immunosuppressive therapy or relapse;
7. with follow-up conditions.</inclusion_criteria>
      <agemin>2</agemin>
      <agemax>55</agemax>
      <gender>Both</gender>
      <exclusion_criteria>1. PNH or Fanconi aplastic anemia;
2. chromosomal analysis showed clonal disease;
3. major organ dysfunction;
4. tumor and the serious infectious diseases;
5. severe infection;
6. others not suitable for Haplo-HSCT.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Platelet engraftment rate;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Neutrophil engraftment;Graft-versus-host disease;Infection and transplantation related mortality;3-year OS;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Capital clinical characteristics fund </source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2015-01-12</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>